| Outgoing Relation(s) |
| dopamine agonist (CHEBI:51065) is a dopaminergic agent (CHEBI:48560) |
| Incoming Relation(s) |
| (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol (CHEBI:64080) has role dopamine agonist (CHEBI:51065) |
| (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol hydrochloride (CHEBI:64078) has role dopamine agonist (CHEBI:51065) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol (CHEBI:63988) has role dopamine agonist (CHEBI:51065) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63978) has role dopamine agonist (CHEBI:51065) |
| N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:64002) has role dopamine agonist (CHEBI:51065) |
| N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol (CHEBI:64004) has role dopamine agonist (CHEBI:51065) |
| N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol (CHEBI:64001) has role dopamine agonist (CHEBI:51065) |
| N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63996) has role dopamine agonist (CHEBI:51065) |
| 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol (CHEBI:64137) has role dopamine agonist (CHEBI:51065) |
| 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol maleate (CHEBI:64134) has role dopamine agonist (CHEBI:51065) |
| amantadine hydrochloride (CHEBI:2619) has role dopamine agonist (CHEBI:51065) |
| apomorphine (CHEBI:48538) has role dopamine agonist (CHEBI:51065) |
| azodopa (CHEBI:195323) has role dopamine agonist (CHEBI:51065) |
| bromocriptine (CHEBI:3181) has role dopamine agonist (CHEBI:51065) |
| cabergoline (CHEBI:3286) has role dopamine agonist (CHEBI:51065) |
| cariprazine (CHEBI:90933) has role dopamine agonist (CHEBI:51065) |
| cariprazine hydrochloride (CHEBI:90932) has role dopamine agonist (CHEBI:51065) |
| carmoxirole (CHEBI:64200) has role dopamine agonist (CHEBI:51065) |
| carmoxirole hydrochloride (CHEBI:64199) has role dopamine agonist (CHEBI:51065) |
| D-520 (CHEBI:232847) has role dopamine agonist (CHEBI:51065) |
| dihydroergotamine (CHEBI:4562) has role dopamine agonist (CHEBI:51065) |
| fenoldopam (CHEBI:5002) has role dopamine agonist (CHEBI:51065) |
| lisuride (CHEBI:51164) has role dopamine agonist (CHEBI:51065) |
| LY404039 (CHEBI:94640) has role dopamine agonist (CHEBI:51065) |
| lysergic acid diethylamide (CHEBI:6605) has role dopamine agonist (CHEBI:51065) |
| mesulergine (CHEBI:73378) has role dopamine agonist (CHEBI:51065) |
| metergoline (CHEBI:64216) has role dopamine agonist (CHEBI:51065) |
| naxagolide (CHEBI:177372) has role dopamine agonist (CHEBI:51065) |
| naxagolide hydrochloride (CHEBI:177381) has role dopamine agonist (CHEBI:51065) |
| pergolide (CHEBI:63617) has role dopamine agonist (CHEBI:51065) |
| pergolide mesylate (CHEBI:8021) has role dopamine agonist (CHEBI:51065) |
| pramipexole (CHEBI:8356) has role dopamine agonist (CHEBI:51065) |
| pramipexole hydrochloride (CHEBI:51147) has role dopamine agonist (CHEBI:51065) |
| pramipexole hydrochloride anhydrous (CHEBI:51148) has role dopamine agonist (CHEBI:51065) |
| quinpirole (CHEBI:75401) has role dopamine agonist (CHEBI:51065) |
| ropinirole (CHEBI:8888) has role dopamine agonist (CHEBI:51065) |
| dexpramipexole (CHEBI:232420) is a dopamine agonist (CHEBI:51065) |
| dopamine receptor D1 agonist (CHEBI:131795) is a dopamine agonist (CHEBI:51065) |
